Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ZOETIS INC
03/21 ZOETIS : to Participate in the Jefferies Animal Health Summit
03/06 ZOETIS : Expands K-9 Courage™ Program to Support Service Dogs Assisting Ve..
02/17 ZOETIS : Statement on the Positive Opinion for Cytopoint Adopted by the European..
02/17 ZOETIS : to Participate in the Cowen and Company 37th Annual Health Care Confere..
02/16DJZOETIS : Dims Outlook
02/16 ZOETIS : tops 4Q profit forecasts
02/16 ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
02/15 ZOETIS : Receives European Commission Approval for Stronghold® Plus
02/15 ZOETIS INC. (NYSE : ZTS) Files An 8-K Regulation FD Disclosure
02/14 ZOETIS : Declares Second Quarter 2017 Dividend
02/13ZOETIS INC : annual earnings release
01/30 ANATARA LIFESCIENCES LTD (ASX : ANR) Receives Second Payment for Detach Under Th..
01/11 ZOETIS : Colleagues Make a Difference in Their Communities
01/03 ZOETIS : PHARMAQ Acquires Fish Vaccination Company Nordland Sett Vaks
2016 ZOETIS : to Host Webcast and Conference Call on Fourth Quarter and Full Year 201..
More most relevant news
All news about ZOETIS INC
03/21 ZOETIS : to Participate in the Jefferies Animal Health Summit
03/16 ZOETIS : New Machine Learning Findings Has Been Reported by Researchers at Zoeti..
03/16 ZOETIS : Reports on Environmental Toxicology from Zoetis Inc. Provide New Insigh..
03/16 ZOETIS : Findings from Zoetis Inc. Update Understanding of Hormone Replacement T..
03/16 ZOETIS : Findings from Zoetis Inc. Provides New Data on Leptospirosis (Evaluatio..
03/16 ZOETIS : Investigators at Zoetis Inc. Target Environmental Toxicology (Reproduct..
03/06 ZOETIS : Expands K-9 Courage™ Program to Support Service Dogs Assisting Ve..
03/02 ZOETIS : to Participate in the Cowen and Company 37th Annual Health Care Confere..
02/25 FDA Issues Final Rule for New Animal Drugs for Use in Animal Feed
02/24 PHIBRO ANIMAL HEALTH : New Animal Drugs for Use in Animal Feed; Approval of New ..
More news
Sector news : Veterinary Drugs
11:53a TEVA PHARMACEUTICAL INDUSTRIES : Pharm says media reports of up to 6,000 layoffs..
03/22 MYLAN : recalls 81,000 EpiPens outside U.S. after reports of failure
03/21DJSANOFI'S PRESCRIPTION FOR GROWTH : Drug Sales in the Middle Kingdom
03/20 FTSE rises to record close after Article 50 trigger date set
03/17DJPFIZER : Files 8K - Other Events
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
More sector news : Veterinary Drugs
News from SeekingAlpha
03/20 ACKMAN'S PERSHING SQUARE :   The Death Spiral Is Accelerating
03/16 Premarket analyst action - healthcare
03/15 ZOETIS : A Well-Loved Leader
02/23 PHIBRO ANIMAL HEALTH : Good Company, Good Performance, Questionable Price
02/17 Tracking George Soros's Portfolio - Q4 2016 Update
02/16 Zoetis (ZTS) Q4 2016 Results - Earnings Call Transcript
Latest Tweets
03/21Zoetis : to Participate in the Jefferies Animal Health Summit  
03/20Zoetis Awards Scholarships To Rising Veterinary Students  
03/20Zoetis : Awards Scholarships to Rising Veterinary Students  
03/20Ackman's Pershing Square:  The Death Spiral Is Accelerating
2
03/17Zoetis upgraded by Zacks Investment Research to hold.  
More tweets
Qtime:63
Advertisement
Financials ($)
Sales 2017 5 163 M
EBIT 2017 1 786 M
Net income 2017 1 077 M
Debt 2017 2 099 M
Yield 2017 0,78%
P/E ratio 2017 25,35
P/E ratio 2018 20,88
EV / Sales 2017 5,54x
EV / Sales 2018 5,16x
Capitalization 26 502 M
More Financials
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Full-screen chart
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 59,5 $
Spread / Average Target 10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC0.64%26 502
JINYU BIO-TECHNOLOGY C..49.34%3 114
DECHRA PHARMACEUTICALS..25.58%1 969
SHANGHAI HILE BIO-TECH..-8.25%1 515
VIRBAC-11.66%1 349
PULIKE BIOLOGICAL ENGI..13.28%1 296
More Results